WIDE WORLD OF STOCKS

Bringing Visibility To The Microcap World

Strikeforce Technologies (SFOR.PK)

Loading… Loading feed

Viral Genetics News (VRAL)

Loading… Loading feed

SMART MONEY VIDEOS

Loading… Loading feed

 

STRIKEFORCE TECHNOLOGIES (SFOR.PK)

ProtectID Competitive Analysis

What Makes ProtectID Different?

Platform Approach


Unlike other products which typically offer a single authentication method, ProtectID offers multiple authentication methods. This enables an enterprise to have a choice and have different authentication methods for different user populations based on risk level, cost and deployment strategies. Because the platform is extensible, newer authentication methods and interfaces can be added making the platform viable into the future.

Multiple "Out-of-Band" Authentication


The ProtectID platform supports five different out-of-band authentication methods, making it the most comprehensive out-of-band authentication solution in the market.

Backup Authentication


ProtectID enables any authentication method to backup any other method. For example, the phone can be used as a backup to a token. Thus existing token installations can deploy ProtectID as a backup authentication scheme and save on help desk costs.

Multiple Deployment Options


ProtectID can be deployed in the following ways:

On a single server

On multiple servers with distributed components

As an Cloud Service where the customer interfaces to the service via HTTP/SOAP/RADIUS

As an "Out-of-Band Cloud Service" wherein the customer stores the authentication data and uses ProtectID as the out-of-band authentication channel


Support for Transaction Authentication

Due to its text-to-speech capability, ProtectID can deliver a summary of the transaction to be authenticated. This is useful in preventing Man-In-The-Middle attacks

KEYSTROKE ENCRYPTION

Though PC users are worried about spyware that tracks web site visits, and crashes their PCs, there are more insidious threats out there. A more powerful breed of spyware can log keystrokes (including passwords and credit card numbers) and send that information to criminals. This type of software is called a keylogger.

What is a keylogger?

A keylogger is a type of surveillance software that has the capability to record every keystroke you make and is logged to a file (usually encrypted). A keylogger can record instant messages, e-mail, and any information you type at any time using your keyboard. The log file created by the keylogger can then be sent to a specified receiver. Some keylogger programs will also record any e-mail addresses you use and Web site URLs you visit.

A keylogger can be inserted into a victim’s computer via several ways. It can be carried by a virus or spyware. It can come as an attachment in an e-mail. For example, the Corporate IT Forum spam email contains a website link, the clicking of which, causes a keylogger to be loaded into the computer. It can even be embedded in an mp3 file or delivered via a XSS (Cross Site Scripting) attack.

Why current anti-virus software is ineffective?

All anti-spam and anti-virus tools are based on scanning a computer for files with a particular signature. The database containing signatures of known bad files have to be continuously updated. The major caveat in this approach is the existence of the signature of a known problematic file. Spammers and criminals are currently deploying sophisticated software which dynamically changes the file signature. Therefore, anti-spam tools are no longer effective against keyloggers. Also, there is significant time between detecting a new keylogger on the Internet and the anti-keylogging signature being updated on anti-virus/spyware software. This time gap can take a month to a couple of months.

How GuardedID protects users

GuardedID uses a different approach to defend against keyloggers. Rather than trying to detect keyloggers, it takes a preventive approach. It takes control of the keyboard at the lowest possible layer in the kernel. The keystrokes are then encrypted and sent to the browser via an “Out-of-Band” channel bypassing the Windows messaging queue. GuardedID has a built in self-monitoring capability. This prevents it from being bypassed by other software. If GuardedID is tampered with in any way, it will warn the user of the breach.
 
 
 

VIDEO OF THE DAY - Dr Robin Shattock

Viral Genetics HIV/AIDS Compound Researched by London Team.

SAN MARINO, Calif. -- June 14, 2010

Biotech company Viral Genetics, Inc., (Pinksheets: VRAL - News) has granted a renowned London research team the right to investigate its HIV/AIDS drug compound. The team is lead by scientist Dr. Robin Shattock.

“This alliance enables us to partner with leading scientists who have tremendous knowledge and resources at their disposal,” said Viral Genetics CEO Haig Keledjian.

Being explored for its potential to offer new therapies and new vaccines for the deadly HIV virus, the technology was discovered and developed by Viral Genetics’ lead scientist Dr. M. Karen Newell, Ph.D.

Viral Genetics’ Georgetown, Texas, team also continues refining a drug that successfully eliminated the viral load in some HIV patients in human clinical trials.

Shattock is professor of cellular and molecular infection in the Department of Cellular and Molecular Medicine at St George's, University of London. He directs scientists working to develop safe and effective vaginal microbicides, topical formulations designed to prevent HIV infection in women. The first generation of these drugs recently entered large-scale Phase III efficacy trials.


According to Shattock, “I am delighted to be working with Dr Karen Newell and Viral Genetics to understand the potential of a panel of newly defined peptides to modulate HIV infection. This represents a highly innovative approach and could provide important new leads in immune-based approaches to HIV prevention and treatment."

Shattock’s research is supported by a Grand Challenges for Global Health Initiative program grant, co-funded by the Wellcome Trust and Gates Foundation. Professor Shattock's team also received funding from the Medical Research Council (UK), European Commission, the National Institutes for Health (USA) and the International Partnership for Micorbicides.

Viral Genetics’ Senior Vice President Monica Ord added, “Professor Shattock is one of the foremost experts on microbicides in the world. This exciting agreement gives our team the opportunity to investigate multiple applications for our peptides in AIDS.”

“It’s encouraging to have so many talented scientists working on applications for our discoveries,” said Newell. “HIV is a terrible disease, and I’d like to see new treatments and new vaccines available as soon as possible.”

Badge

Loading…

Sign Up for your free membership to Wide World Of Stocks and Receive Our FREE NEWSLETTER !!

© 2012   Created by Imperial Consulting Network.

Badges  |  Report an Issue  |  Terms of Service